Colorectal cancer: open trials in Switzerland

23 open trials have a site in Switzerland. Registry data; only the trial team decides who can take part.

NCT06760819
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Trial Treatment · Phase 2 · Bayer
Inselspital Bern - Universitätsklinik für Medizinische Onkologie, Bern · Hopitaux Universitaires de Geneve - Oncology Department, Geneva · UniversitätsSpital Zürich (USZ) - Klinik für Medizinische Onkologie und Hämatologie, Zurich
Registry updated 2026-11-04
NCT07284849
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Trial Treatment · Phase 3 · Incyte Corporation
Inselspital - Universitaetsspital Bern, Bern · Chuv, Lausanne University Hospital, Lausanne · Hoch Health Ostschweiz, Sankt Gallen
Registry updated 2026-10-30
NCT06428409
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Ospedale Regionale Bellinzona e Valli (Site 0201), Bellinzona · Hôpitaux Universitaires de Genève (HUG) (Site 0202), Geneva
Registry updated 2026-10-29
NCT07811193
A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Trial Treatment · Phase 2 · Vividion Therapeutics, Inc.
UniversitätsSpital Zürich (USZ) - Klinik für Medizinische Onkologie und Hämatologie, Zurich
Registry updated 2026-10-21
NCT05176483
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Trial Treatment · Phase 1 · Exelixis
Chur · Sankt Gallen · Winterthur
Registry updated 2026-10-01
NCT05489211
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Trial Treatment · Phase 2 · AstraZeneca
Basel · Bellinzona · Sankt Gallen
Registry updated 2026-09-23
NCT07829081
Research on Effective Strategies After Immunotherapy for Mismatch Repair-deficient Early-stage GI Tumors
Research · University Hospital, Basel, Switzerland
Universitätsspital Basel, Basel · Spitalzentrum Biel, Biel · Luzerner Kantonsspital, Lucerne
Registry updated 2026-09-18
NCT06252649
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Trial Treatment · Phase 3 · Amgen
Universitaetsspital Zuerich, Zurich
Registry updated 2026-09-03
NCT06562192
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Trial Treatment · Phase 1 · Novartis Pharmaceuticals
Geneva · Lausanne
Registry updated 2026-07-29
NCT06943612
Colorectal Resections in Patients With Retroperitoneal Sarcoma
Research · Heidelberg University
Sarcoma Center University of Basel, Basel
Registry updated 2026-07-23
NCT05253651
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Trial Treatment · Phase 3 · Seagen, a wholly owned subsidiary of Pfizer
Zuripharm AG, Schlieren · Universitatsspital Zurich - Klinik fur Medizinische Onkologie und Hamatologie USZ, Zurich
Registry updated 2026-07-22
NCT07617610
Primary and Acquired Resistance to Targeted Treatment in BRAF V600E-mutated Metastatic Colorectal Cancer
Research · Swiss Cancer Institute
Kantonsspital Aarau, Aarau · Kantonsspital Baden, Baden · Universitaetsspital Basel, Basel · St. Claraspital, Basel · Inselspital Bern, Bern · Spitalzentrum Biel - MEDIN La Tour, Biel · Kantonsspital Graubunden, Chur · Luzerner Kantonsspital, Lucerne · HOCH Health Ostschweiz - Kantonsspital St. Gallen, Sankt Gallen · Bürgerspital Solothurn, Solothurn · HFR Freiburg - Kantonsspital, Villars-sur-Glâne · Kantonsspital Winterthur, Winterthur · Universitätsspital Zürich USZ, Zurich
Registry updated 2026-07-16
NCT04184973
Efficacy and Safety of the CG-100 Intraluminal Bypass Device
Trial Treatment · Colospan Ltd.
CHUV, Lausanne
Registry updated 2026-07-06
NCT06567782
A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer
Trial Treatment · Phase 2 · GlaxoSmithKline
Bern · Geneva
Registry updated 2026-05-22
NCT06936774
Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance
Trial Treatment · Phase 3 · University Hospital, Basel, Switzerland
Clarunis Universitäres Bauchzentrum Basel, Basel · St. Anna Spital Bern, Bern · Lindenhofspital Bern, Bern · Kantonsspital Luzern, Lucerne · Kantonsspital Winterthur, Winterthur
Registry updated 2026-05-06
NCT06249672
Longterm Functional Outcomes in Patients Undergoing Organ Preserving Treatment for Rectal Cancer With or Without Local Excision After Chemoradiotherapy
Research · Insel Gruppe AG, University Hospital Bern
Bern University Hospital, Inselspital, Bern
Registry updated 2026-05-05
NCT07280143
The Development of MASLD Among Survivors of Breast or Colorectal Cancer
Research · University of Bern
Department of Clinical Research, University of Bern, Bern
Registry updated 2025-12-12
NCT05748145
Metronidazole as Preoperative Therapy in CRC / FusoMetro-001
Trial Treatment · Phase 2 · Oncology Institute of Southern Switzerland
Oncology Institute of Southern Switzerland, Bellinzona
Registry updated 2025-11-18
NCT06154785
Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)
Research · Bordeaux Colorectal Institute Academy
Hôpitaux universitaires de Genève, Geneva
Registry updated 2025-08-01
NCT06462963
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
Trial Treatment · European Organisation for Research and Treatment of Cancer - EORTC
Inselspital - Inselspital, Bern · Universitaetsspital Zürich, Zurich
Registry updated 2025-08-01
NCT05428735
The DRAGON 2 Trial
Trial Treatment · Maastricht University
Claraspital & Clarunis University Hospital Basel, Basel · Kantonsspital Winterthur KSW, Winterthur
Registry updated 2024-11-01
NCT04498767
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Trial Treatment · European Organisation for Research and Treatment of Cancer - EORTC
Inselspital, Bern · Universitaetsspital Zürich, Zurich
Registry updated 2024-08-26
NCT04109755
Neo-adjuvant Pembrolizumab and Radiotherapy in Localised MSS Rectal Cancer
Trial Treatment · Phase 2 · University Hospital, Geneva
Hôpitaux universitaires de Genève, Geneva
Registry updated 2021-09-30

All Colorectal cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error